Beacon Biomedical

Beacon Biomedical Inc. is a CLIA-accredited proteomic diagnostics laboratory focused on developing and commercializing laboratory-developed tests, including a diagnostic device designed to detect colorectal cancer in its early stages. The company raised $1.47M and was later acquired by CashLabs LLC in 2022.